Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1984-12-03
1987-03-17
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Lymphokine
435 68, 514 12, A61K 4502, C12P 2100
Patent
active
046506748
ABSTRACT:
Compositions comprising an interferon and a cytotoxic protein designated tumor necrosis factor exhibit a synergistic cytotoxic effect on tumor cells.
REFERENCES:
patent: 4457916 (1984-07-01), Hayashi et al.
Baron, S. et al., Annals New York Academy of Sciences, pp. 130-144, 1980.
Chemical Abstracts, vol. 92, Abstract No. 108513h, 1980.
Oettgen, H. et al., Recent Results Cancer Research, vol. 75, pp. 207-212, 1980.
Yabrov, A., Medical Hypotheses, vol. 5, pp. 769, 783-785, 1979.
Stone-Wolff et al., "J. Exp. Med." 159: 828-843 (Mar. 1984).
Papermaster et al., "Human Lymphokines" Khan et al., Ed. 459-477 (Jun. 30, 1982).
Armstrong et al., "J.N.C.I." 74(1): 1-9 (Jan. 1985).
Flick et al., "Biological Response Modifiers", P. F. Torrence, ED. pp. 171-218 (1985).
Buessow et al., "Leukemia Research" 8(5): 801-811 (1984).
Williams et al., "J. of Immunology" 130(2): 518-520 (Feb. 1983).
Fleischmann, "Cancer Research" 42: 869-875 (Mar. 1982).
Williamson et al., "P.N.A.S. USA" 80: 5397-5401 (Sep. 1983).
Ostrove et al., "Proc. of the Society for Experimental Biology and Medicine" 160: 354-358 (1979).
Gray et al., "Nature" 312: 721-724 (20/27 Dec. 1984).
Matthews "Br. J. Cancer" 40: 534-539 (1979).
Matsunaga et al., "Cancer Letters" 20: 21-28 (1983) Elsevier Sci. Publishers Ireland Ltd.
Aggarwal Bharat B.
Lee Sang He
Genentech Inc.
Hazel Blondel
LandOfFree
Synergistic cytotoxic composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synergistic cytotoxic composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synergistic cytotoxic composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1787780